Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,355 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $865.18 | 7 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $131.37 | 1 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $122.91 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $118.53 | 1 | $0 (2018) |
| PFIZER INC. | $117.38 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $379.28 | 3 | SANOFI-AVENTIS U.S. LLC ($131.37) |
| 2023 | $238.57 | 2 | Novo Nordisk Inc ($121.19) |
| 2022 | $247.88 | 2 | Novo Nordisk Inc ($247.88) |
| 2021 | $249.90 | 2 | Novo Nordisk Inc ($249.90) |
| 2020 | $121.21 | 1 | Novo Nordisk Inc ($121.21) |
| 2018 | $118.53 | 1 | Merck Sharp & Dohme Corporation ($118.53) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $131.37 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
| 02/29/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $122.91 | General |
| Category: Insomnia | ||||||
| 11/16/2023 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $117.38 | General |
| Category: VACCINES | ||||||
| 06/28/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.19 | General |
| 08/18/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $122.90 | General |
| Category: Diabetes | ||||||
| 02/17/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Diabetes | ||||||
| 10/14/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.91 | General |
| Category: Diabetes | ||||||
| 06/03/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diabetes | ||||||
| 01/23/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $121.21 | General |
| Category: Diabetes | ||||||
| 07/24/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $118.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 666 | 1,300 | $378,341 | $113,630 |
| 2022 | 10 | 625 | 1,327 | $379,448 | $103,166 |
| 2021 | 10 | 668 | 1,431 | $416,748 | $115,494 |
| 2020 | 9 | 527 | 1,136 | $327,403 | $93,333 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 151 | 408 | $89,352 | $25,851 | 28.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 92 | 250 | $69,750 | $23,842 | 34.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 96 | 249 | $79,182 | $23,817 | 30.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 123 | 142 | $46,718 | $13,486 | 28.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 47 | 48 | $24,336 | $7,804 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Office | 2023 | 38 | 73 | $15,987 | $4,752 | 29.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 26 | $16,120 | $3,582 | 22.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Office | 2023 | 31 | 33 | $10,857 | $3,135 | 28.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Office | 2023 | 18 | 25 | $7,950 | $2,424 | 30.5% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 19 | 19 | $6,137 | $2,254 | 36.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Office | 2023 | 15 | 15 | $9,300 | $1,863 | 20.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $2,652 | $820.87 | 31.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 153 | 483 | $105,777 | $27,739 | 26.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 79 | 260 | $72,540 | $21,582 | 29.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 94 | 242 | $76,956 | $20,485 | 26.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 113 | 138 | $45,402 | $12,360 | 27.2% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 39 | 40 | $20,280 | $5,975 | 29.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 24 | $14,880 | $3,837 | 25.8% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Office | 2022 | 35 | 47 | $14,993 | $3,523 | 23.5% |
| 99217 | Hospital observation care on day of discharge | Office | 2022 | 49 | 51 | $11,424 | $2,829 | 24.8% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 25 | 27 | $8,721 | $2,599 | 29.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Office | 2022 | 15 | 15 | $8,475 | $2,237 | 26.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 111 | 343 | $108,798 | $29,457 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 163 | 486 | $106,434 | $29,250 | 27.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 87 | 262 | $73,098 | $21,909 | 30.0% |
About Dr. Mario Mutic, MD
Dr. Mario Mutic, MD is a Internal Medicine healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083681993.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mario Mutic, MD has received a total of $1,355 in payments from pharmaceutical and medical device companies, with $379.28 received in 2024. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($1,355).
As a Medicare-enrolled provider, Mutic has provided services to 2,486 Medicare beneficiaries, totaling 5,194 services with total Medicare billing of $425,623. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location White Plains, NY
- Active Since 03/01/2006
- Last Updated 01/13/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083681993
Products in Payments
- Ozempic (Drug) $496.09
- TZIELD (Biological) $131.37
- Wegovy (Drug) $125.00
- QUVIVIQ (Drug) $122.91
- Rybelsus (Drug) $122.90
- ZERBAXA (Drug) $118.53
- ABRYSVO (Biological) $117.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in White Plains
Tomrul Tuzel, M.d, M.D
Internal Medicine — Payments: $113,652
Dr. Sharon Parish, Md, MD
Internal Medicine — Payments: $74,824
Despoina Michailidou, Md, MD
Internal Medicine — Payments: $73,621
Daniel Wang, M.d, M.D
Internal Medicine — Payments: $19,656
Dr. Breta Boots, Do, DO
Internal Medicine — Payments: $9,255
Dr. Vivian Volterre, M.d, M.D
Internal Medicine — Payments: $7,003